Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K203711
    Device Name
    IWL2020 Blood Glucose Monitoring System
    Manufacturer
    Roche Diabetes Care Inc.
    Date Cleared
    2022-05-06

    (501 days)

    Product Code
    NBW
    Regulation Number
    862.1345
    Why did this record match?
    Applicant Name (Manufacturer) :

    Roche Diabetes Care Inc.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
    Intended Use
    The IWL2020 Blood Glucose Monitoring System is comprised of the IWL2020 meter and IWL2020 test strips. The IWL2020 Blood Glucose Monitoring System is intended to quantitatively measure glucose in fresh capillary whole blood from the fingertip as an aid in monitoring the effectiveness of glucose control. The IWL2020 Blood Glucose Monitoring System is intended for in vitro diagnostic single patient use by people with diabetes at home. The IWL2020 Blood Glucose Monitoring System is intended to be used by a single person and should not be shared. This system is not for use in diagnosis or screening of diabetes mellitus, nor for neonatal use.
    Device Description
    The IWL2020 Blood Glucose Monitoring System consists of the following components: - IWL2020 Meter - IWL2020 Blood Glucose Test Strips - IWL2020 Control Solutions The IWL2020 Blood Glucose Monitoring System is a handheld device that incorporates features to aid in self-monitoring of blood glucose. The blood glucose results are displayed on the screen and stored in the meter's memory, and may also be transmitted via Bluetooth Low Energy (BLE) wireless communication. Our blood glucose monitoring system creates a glucose result from an amperometric reaction. Capillary whole blood from the user's fingertip reacts with the chemicals in the test strip to create a harmless electrical current in the test strip. The blood glucose meter reads the current and gives a blood glucose result.
    Ask a Question
    K Number
    K150910
    Device Name
    ACCU-CHEK Connect Diabetes Management App
    Manufacturer
    ROCHE DIABETES CARE INC.
    Date Cleared
    2015-06-03

    (61 days)

    Product Code
    NDC, JQP, LFR, LZG
    Regulation Number
    868.1890
    Why did this record match?
    Applicant Name (Manufacturer) :

    ROCHE DIABETES CARE INC.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
    Intended Use
    The ACCU-CHEK Connect Diabetes Management App is indicated as an aid in the treatment of diabetes. The software provides for electronic download of blood glucose meters, manual data entry, storage, display, transfer, and self-managing of blood glucose and other related health indicators which can be shown in report and graphical format. The ACCU-CHEK Bolus Advisor, as a component of the ACCU-CHEK Connect Diabetes Management App, is indicated for the management of diabetes by calculating an insulin dose or carbohydrate intake based on user-entered data. Before its use, a physician or healthcare professional must activate the bolus calculator and provide the patient-specific target blood glucose. insulin-to-carbohydrate ratio, and insulin sensitivity parameters to be programmed into the software.
    Device Description
    The ACCU-CHEK Connect Diabetes Management App is designed to facilitate efficient collecting, transmitting, and analyzing of blood glucose results and other diabetes management data. The App helps: Wireless transfer of data from ACCU-CHEK Aviva Connect Blood Glucose Meter. Assist in general diabetes management through logging of contextual data. ACCU-CHEK Bolus Advisor support of mealtime insulin dosing calculations. Perform structured testing. Wireless transfer of data from mobile devices to ACCU-CHEK Connect Online Diabetes Management System and optionally share this data with healthcare provider (HCP) or caregiver. The insulin bolus calculations provided by the app are meant for patients undergoing multiple daily injection therapy. Bolus calculators, such as the ACCU-CHEK Bolus Advisor, have been demonstrated to facilitate the optimization of glycemic control in patients who are trained in multiple daily insulin injection therapy and under the supervision of healthcare professional experienced in managing insulin-treated patients. Such calculators have also been shown to reduce patient fear of hypoglycemia and improve patient confidence in diabetes management. The ACCU-CHEK Connect Diabetes Management App is not intended to serve as an accessory to an insulin pump.
    Ask a Question

    Page 1 of 1